Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Akso Health Group (AHG) Cash Flow Statement

Akso Health Group (AHG) generated -$12.8M of operating cash flow over the twelve months to its latest filing, spent $1638 on capital expenditure and had free cash flow of -$12.8M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · read by EquiReason

AHGAkso Health GroupFollow AHG — free
Specialty Business Services · Industrials
—
Price chart with a free account
Market cap
1.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
—
LineFY2019
Mar 19
FY2020
Mar 20
FY2021
Mar 21
FY2022
Mar 22
FY2023
Mar 23
FY2024
Mar 24
FY2025
Mar 25
FY2026
Mar 26
TTM
Trend
Operating cash flow-1.7-58.310.1-8.6-3.31.41.2-12.8-12.8
Capital expenditure0.00.2—0.0——0.20.0-0.0
Free cash flow-1.7-58.5—-8.6——1.0-12.8-12.8
Dividends paid19.5————————
Share repurchases1.32.7———————
Stock-based compensation6.60.30.10.4—————

USD millions · SEC XBRL

Akso Health Group — questions

What is Akso Health Group's operating cash flow?
-$12.8M over the twelve months to the latest filing.
How much does Akso Health Group spend on capital expenditure?
$1638 over the twelve months to the latest filing.
What is Akso Health Group's free cash flow?
-$12.8M over the twelve months to the latest filing: operating cash flow minus capital expenditure.

Every figure on this page comes from Akso Health Group's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.